Multinational drug corporations withstand against expensive medication controls.

Published: 2001-07-02 06:59:00

Updated: 2001-07-02 06:59:00

Foreign multinational drug corporations in Korea strongly resisted against the NHIC's insurance reimbursement controls over the medication of expensive drugs mostly supplied by their products, claiming it as a short-sighted measure that not only infringes physician's prescription rights but also ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK